Lavinia A. Spain
Fitzroy, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Development of a Digital Phenotype for Immune-Related Colitis.
Journal: JCO clinical cancer informatics
Published: June 16, 2026
Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experience.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 06, 2026
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials.
Journal: European urology
Published: November 03, 2025
[177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study.
Journal: The Lancet. Oncology
Published: October 07, 2025
Treatment preferences of patients and physicians for early-stage and adjuvant treatment of urothelial carcinoma and renal cell carcinoma in Asia-Pacific: a discrete choice experiment.
Journal: BMC urology
Published: September 15, 2025
Impact of stereotactic radiosurgery timing relative to immune checkpoint blockade administration on brain metastasis disease and radionecrosis outcomes.
Journal: Neuro-oncology advances
Published: July 28, 2025
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors.
Journal: Journal for immunotherapy of cancer
Published: July 21, 2025
Long-term clinical outcomes of bevacizumab for treatment of stereotactic radiosurgery-induced radiation necrosis in patients with brain metastases.
Journal: Journal of neuro-oncology
Published: May 03, 2025
Neuroimaging features of immune-related adverse events due to immune checkpoint inhibitor therapy.
Journal: Insights into imaging
Published: December 31, 2024
Last Updated: 09/26/2026